Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 93.63M P/E - EPS this Y -399.80% Ern Qtrly Grth -
Income -112.24M Forward P/E -1.70 EPS next Y 61.70% 50D Avg Chg -10.00%
Sales 53.87M PEG -0.01 EPS past 5Y - 200D Avg Chg -4.00%
Dividend N/A Price/Book 3.49 EPS next 5Y 61.20% 52W High Chg -50.00%
Recommedations 1.60 Quick Ratio 4.21 Shares Outstanding 7.04M 52W Low Chg 126.00%
Insider Own 4.73% ROA -15.66% Shares Float 4.21M Beta 1.03
Inst Own 54.15% ROE -153.39% Shares Shorted/Prior 65.14K/99.24K Price 1.04
Gross Margin -19.30% Profit Margin -211.35% Avg. Volume 876,140 Target Price 57.25
Oper. Margin -3,675.83% Earnings Date Oct 31 Volume 710,387 Change 0.00%
About Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. The company was incorporated in 2012 and is based in San Diego, California.

Cidara Therapeutics, Inc. News
08:30 AM Cidara Therapeutics Announces $105 Million Private Placement
11/19/24 Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference
11/07/24 Cidara Therapeutics: Q3 Earnings Snapshot
10/31/24 Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences
10/16/24 Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024
10/04/24 Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
09/25/24 Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference
09/23/24 Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
09/19/24 Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts
09/13/24 Cidara axes 30% of staff to focus on flu prevention drug
09/13/24 Cidara buys back rights to flu therapy from J&J for $85m
09/12/24 Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388
09/05/24 Cidara to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/19/24 Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer
08/13/24 Cidara Therapeutics: Q2 Earnings Snapshot
08/13/24 Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
05/30/24 Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference
05/15/24 Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
05/15/24 Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules
04/26/24 Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024
CDTX Chatroom

User Image tradingtwenty Posted - 50 minutes from now

$CDTX has trended 2 times in the past 24 hours (based on 5 minute intervals). Latest press release on Nov 21, 2024 08:30 AM: Cidara Therapeutics Announces $105 Million Private Placement Link: https://tradingtwenty.com/news/711402/cidara-therapeutics-announces-105-million-private-placement

User Image PharmaExpert Posted - 40 minutes from now

$AKBA, $CDTX, $DRIO, $ALT, $AVXL ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ

User Image Pedelco Posted - 35 minutes from now

$CDTX ready to fly ๐Ÿ˜

User Image veryboredXYZ Posted - 2 minutes ago

$CDTX

User Image bernardbaruch Posted - 12 minutes ago

$CDTX nice, congrats OG

User Image Bloenten Posted - 50 minutes ago

$CDTX LFG! Still with a loss.. but damn this feels good! Iโ€™m holding till this company cures cancer!

User Image BigTpain Posted - 58 minutes ago

$CDTX ๐Ÿ˜

User Image IkerBall Posted - 1 hour ago

$ARQQ $CDTX waiting for a breakout. I'm on the bulls' side. ๐Ÿ”ฅ Bolt Metals (BOLT.CN) +12.7660% Volume 210k more than avg 120%. ๐Ÿšจ PR INCOMING. Bought the dip ystrd. Another ticker got my attention yesterday with 440k volume (+6x avg). YTD Return +68.75%. L-Float + Mkt cap <$10M. PT: $0.55 (+100%) Upside is MASSIVE.

User Image ItsOnlyUrMoney Posted - 1 hour ago

$CDTX

User Image rickahuna Posted - 1 hour ago

$CDTX Now does anyone question the incredible science behind Cidara...or Cali's $300 pps in August lol

User Image _nic Posted - 1 hour ago

$CDTX huge swings

User Image Windee Posted - 2 hours ago

$CDTX Nice private placement $105 million!!

User Image liloleme4 Posted - 2 hours ago

$CDTX Glad to finally see some real life in this one! I just looked... 3 years ago tomorrow I bought my first shares, with some selling, but mostly buying and one big RS since then!

User Image Enodloca Posted - 2 hours ago

$CDTX Management knows the power and future of CD388 (and others). Now a few others do as well!

User Image CaliEmpress Posted - 2 hours ago

$CDTX I knew it ๐Ÿฅ‚

User Image GreylockSec Posted - 2 hours ago

@OA_Trades @TAKERS1 @Leon_32 $TPST Thank you Renaud! for the alert on the $CDTX also landing a nice private placement & also catapulting 35% this morning on the news. That now makes 3 private placement deals all developing into huge investor interest. I plan to write my little persuasive letter this weekend to Brady & the CFA at Tempest highlighting the market's incredible reaction to the 3 deals $DRUG $FBRX that got their stocks rumbling. This is why I keep adding small buys even though I'm still looking for a better entry point a bit lower - we just don't know if Brady already has something cooking in the kettle that will wake us up one morning with a trade halt, to later open up at $15 ๐Ÿ€

User Image Lstreak Posted - 2 hours ago

$CDTX Fly baby!!

User Image ManfredMustermann Posted - 2 hours ago

$CDTX Yeah

User Image Bananya Posted - 2 hours ago

$CDTX

User Image topstockalerts Posted - 2 hours ago

Pre Market Top Gainers PT2 $PET $XAIX $AKTS $CDTX $MSTX

User Image StockElementCorporation Posted - 2 hours ago

Premarket movers ๐Ÿ“ˆ $SNOW +24% (earnings, guidance; signs multi-year partnership with Anthropic to deliver Claude models to customers in Snowflake's Cortex AI) $CDTX +19% $MSTR +14% $CRNC +11% $WALD +11% VNET +6.4% SMCI +5.2% WKSP +4.0% (CEO buys 33.3K shares at 44% premium to market) SRAD +2.3% NVDA +2.2% BJ +2.1% Downside: PYXS -40% (reports study data for PYX-201)

User Image scalp_scalpnyc Posted - 2 hours ago

$FBRX 30+++++$SPAI $WORX $CDTX

User Image CaliEmpress Posted - 2 hours ago

$CDTX The best part is that Cidara did not need the money, just paying favors to special friends. And you never ever screw up or mislead that kind of friends.

User Image OpenOutcrier Posted - 2 hours ago

$CDTX (+27.8% pre) Cidara Therapeutics Secures $105M Private Placement Led by Venrock Healthcare https://ooc.bz/l/48998

User Image insanitywolftrading Posted - 2 hours ago

$CDTX boom!

User Image Scanners_Free Posted - 2 hours ago

$CDTX NEWSSSSSSS OUTTTTTTTTT

User Image Purch Posted - 2 hours ago

$CDTX

User Image Jay_Gapsby Posted - 2 hours ago

$CDTX can we see triple digits? ๐Ÿ‘€

User Image _nic Posted - 2 hours ago

$CDTX 20 today

User Image sng383838 Posted - 2 hours ago

$CDTX This $105 million private placement significantly bolsters Cidara's financial position, nearly doubling its market cap of $114.9 million. The deal structure at $14.912 per share represents a strategic financing approach combining direct stock sales and pre-funded warrants. The participation of prominent healthcare investors like Venrock, RA Capital and BVF Partners adds credibility and suggests strong institutional confidence in Cidara's Cloudbreakยฎ platform and pipeline. The substantial capital injection will extend Cidara's operational runway and accelerate their drug-Fc conjugate immunotherapy development. With approximately $7 million shares being issued between common stock and warrants, this deal does introduce notable dilution but provides essential growth capital. The commitment to file a registration statement for resale indicates good corporate governance and provides future liquidity for investors.

Analyst Ratings
HC Wainwright & Co. Buy Aug 14, 24
Cantor Fitzgerald Overweight Aug 14, 24
Needham Buy Aug 14, 24
Cantor Fitzgerald Overweight Jun 20, 24
Needham Buy May 16, 24
WBB Securities Strong Buy Apr 25, 24
Needham Buy Apr 25, 24
Cantor Fitzgerald Overweight Apr 25, 24
Cantor Fitzgerald Overweight Apr 23, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Tari Leslie CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Aug 14 Buy 0.97 10,000 9,700 294,179 08/14/23
Stein Jeffrey President & CEO President & CEO Aug 08 Buy 0.9577 50,000 47,885 331,602 08/08/23
Stein Jeffrey President & CEO President & CEO Mar 27 Buy 1.0371 50,000 51,855 281,602 03/27/23
Ward Shane COO & CLO COO & CLO Mar 13 Sell 1.53 4,329 6,623 84,576 03/13/23
Tari Leslie CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Mar 13 Sell 1.53 7,562 11,570 190,179 03/13/23
Shah Preetam CFO & CBO CFO & CBO Mar 13 Sell 1.53 6,648 10,171 148,141 03/13/23
Sandison Taylor Chief Medical Office.. Chief Medical Officer Mar 13 Sell 1.53 7,203 11,021 288,550 03/13/23
Sandison Taylor Chief Medical Office.. Chief Medical Officer Sep 12 Sell 0.6849 18,478 12,656 291,753 09/13/22
Tari Leslie CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Sep 12 Sell 0.6849 18,159 12,437 193,741 09/13/22
Daruwala Paul Chief Operating Offi.. Chief Operating Officer Sep 12 Sell 0.6849 16,199 11,095 221,099 09/13/22
Johnson Brady Vice President, Fina.. Vice President, Finance Mar 21 Sell 0.81 654 530 49,366 03/23/22
Johnson Brady Vice President, Fina.. Vice President, Finance Mar 11 Sell 0.71 945 671 50,020 03/11/22
Daruwala Paul Chief Operating Offi.. Chief Operating Officer Dec 29 Option 0 9,900 192,431 01/07/22
Daruwala Paul Chief Operating Offi.. Chief Operating Officer Dec 29 Sell 1.25 5,133 6,416 187,298 01/07/22
Stein Jeffrey President & CEO President & CEO Dec 29 Option 0.00 20,000 489,878 01/07/22
Johnson Brady Vice President, Fina.. Vice President, Finance Dec 29 Option 0 262 51,381 01/07/22
Johnson Brady Vice President, Fina.. Vice President, Finance Dec 29 Sell 1.25 416 520 50,965 01/07/22
Sandison Taylor Chief Medical Office.. Chief Medical Officer Dec 29 Option 0.00 15,600 256,231 01/07/22
Tari Leslie Chief Scientific Off.. Chief Scientific Officer Dec 29 Option 0 2,101 156,652 01/07/22
Tari Leslie Chief Scientific Off.. Chief Scientific Officer Dec 29 Sell 1.25 1,252 1,565 155,400 01/07/22
Daruwala Paul Chief Operating Offi.. Chief Operating Officer Apr 05 Sell 2.36 3,461 8,168 50,531 04/05/21